УДК 616.65-006.6-07
I.B. Chigireva1, R.Sh. Khasanov2, S.V. Panchenko1, M.G. Sharafutdinov3
1Regional Clinical Oncology Center, Ulyanovsk
2Kazan State Medical Academy, Kazan
3Ulyanovsk State University, Ulyanovsk
Chigireva I.B. ― Deputy chief physician for organizational and methodical work of the Regional Clinical Oncology Center
90 12 Sentyabrya St., Ulyanovsk, Russian Federation, 432017, tel.: (8422) 32-61-03, +7-927-818-16-76, e-mail: inchy08@yandex.ru
Abstract. A prostate cancer is one of the most widespread malignant tumor at men from all over the world. Article represents the review of modern methods of diagnosis of prostate diseases. This definition a prostate-specific antigen test, digital rectal examination, transrectal ultrasonography, sonoelastography, urinary prostate cancer antigen 3. Sensitivity and specificity of each method is shown.
Key words: prostate cancer, prostate-specific antigen, digital rectal examination, urinary prostate cancer antigen 3, sonoelastography, РСА3.
REFERENCES
1. Apolikhin O.I., Sivkov A.V., Beshliev D.A. et al. Analysis uronefrologicheskoy morbidity in the Russian Federation, according to official statistics. Eksperimental'naya i klinicheskaya urologiya, 2010, no. 1, pp. 4-10 (in Russ.).
2. Kaprin A.D., Starinskiy V.V., Petrova G.V. Zlokachestvennye novoobrazovaniya v Rossii v 2013 godu (zabolevaemost' i smertnost') [Malignancies in Russia in 2013 (morbidity and mortality)]. Moscow: FGBU “MNIOI im P.A. Gertsena” Minzdrava Rossii, 2015. 235 p.
3. Carter H.B., Albertsen P.C., Barry M.J. et al. Early detection of prostate cancer: AUA guideline. J. Urol, 2013, 190, pp. 419-426.
4. Heidenreich A., Abrahamsson P.A., Artibani W. et al. Early detection of prostate cancer: European Association of Urology recommendation. Eur. Urol, 2013, 64, pp. 347-354.
5. Ilic D., Neuberger M.M., Djulbegovic M. et al. Screening for prostate cancer. Cochrane Database Syst. Rev., 2013 Jan. 31; 1, available at: http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD004720.pub3/abstract
6. Kim E.H., Andriole G.L. Prostate-specific antigen-based screening: controversy and guidelines. BMC Med, 2015, 13, p. 61.
7. Murphy D.G., Ahlering T., Catalona W.J. et al. The Melbourne Consensus Statement on the early detection of prostate cancer. BJU Int, 2014, 113, pp. 186-188.
8. Qaseem A., Barry M.J., Denberg T.D. et al. Screening for prostate cancer: a guidance statement from the clinical guidelines committee of the American College of Physicians. Ann. Intern. Med, 2013, 158, pp. 761-769.
9. Schröder F.H., Roobol M.J., Bangma C.H. Early detection of prostate cancer ― Recommendations after 13 years of follow-up in the European randomised study. Ned. Tijdschr Geneeskd, Apr., 2015, 159 (0), p. 8677.
10. WHO: IARC/ Globocan 2012: Estimated Cancer Incidence Mortality and Prevalence Worldwide in 2012, available at: http://globocan.iarc.fr/Pages/fact_sheets_population.asp